Skip to main navigation Skip to search Skip to main content

Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques

Research output: Contribution to journalArticlepeer-review

Abstract

Allogeneic hematopoietic stem cell transplantation (alloHSCT) from donors lacking C-C chemokine receptor 5 (CCR5Δ32/Δ32) can cure HIV, yet mechanisms remain speculative. To define how alloHSCT mediates HIV cure, we performed MHC-matched alloHSCT in SIV+, anti-retroviral therapy (ART)-suppressed Mauritian cynomolgus macaques (MCMs) and demonstrated that allogeneic immunity was the major driver of reservoir clearance, occurring first in peripheral blood, then peripheral lymph nodes, and finally in mesenteric lymph nodes draining the gastrointestinal tract. While allogeneic immunity could extirpate the latent viral reservoir and did so in two alloHSCT-recipient MCMs that remained aviremic >2.5 years after stopping ART, in other cases, it was insufficient without protection of engrafting cells afforded by CCR5-deficiency, as CCR5-tropic virus spread to donor CD4+ T cells despite full ART suppression. These data demonstrate the individual contributions of allogeneic immunity and CCR5 deficiency to HIV cure and support defining targets of alloimmunity for curative strategies independent of HSCT.

Original languageEnglish (US)
Pages (from-to)1649-1663.e5
JournalImmunity
Volume56
Issue number7
DOIs
StatePublished - Jul 11 2023

Funding

We thank Amgen, Inc. for providing Neupogen, Bristol Myers Squibb for providing Nulojix, Gilead Sciences, Inc. for providing TDF and FTC, ViiV Healthcare for providing DTG, Brandon Keele for providing the SHIV-AD8-EOM virus, William Sutton and Nancy Haigwood for providing SIVmac239 gp140 trimer, and the ONPRC research support and animal care staff for their work with the study animals. We also wish to acknowledge the animals that contributed to this study and express our respect and gratitude for their invaluable role in this research. This work was supported by the National Institutes of Health grants AI112433 and AI129703 awarded to J.B.S. and P51 OD011092 awarded to the Oregon National Primate Research Center (ONPRC). The ONPRC Molecular Virology Support Core and Integrated Pathology Core provided support services for this research. This work was also supported by The Foundation for AIDS Research (amfAR) grant 108832 awarded to J.B.S. with support from Foundation for AIDS Immune Research (FAIR). Graphical abstract created with BioRender.com . We thank Amgen, Inc. for providing Neupogen, Bristol Myers Squibb for providing Nulojix, Gilead Sciences, Inc. for providing TDF and FTC, ViiV Healthcare for providing DTG, Brandon Keele for providing the SHIV-AD8-EOM virus, William Sutton and Nancy Haigwood for providing SIVmac239 gp140 trimer, and the ONPRC research support and animal care staff for their work with the study animals. We also wish to acknowledge the animals that contributed to this study and express our respect and gratitude for their invaluable role in this research. This work was supported by the National Institutes of Health grants AI112433 and AI129703 awarded to J.B.S. and P51 OD011092 awarded to the Oregon National Primate Research Center (ONPRC). The ONPRC Molecular Virology Support Core and Integrated Pathology Core provided support services for this research. This work was also supported by The Foundation for AIDS Research (amfAR) grant 108832 awarded to J.B.S. with support from Foundation for AIDS Immune Research (FAIR). Graphical abstract created with BioRender.com. Conceptualization, J.B.S.; methodology, H.L.W. K.B.-S. B.N.B. T.R.H. L.D.M. R.F.S. J.D.S. J.D.E. J.V.S. G.M. R.T.M. B.J.B. J.J.S. and J.B.S.; investigation, H.L.W. K.B.-S. W.C.W. C.M.W. C.D.B. K.B.B. J.S.R. J.M.H. C.S.-M. T.S. M.N. K.A. H.P. M.R.-L. S.U. M.R.K. E.J.F. S.T.-B. S.B. S.L.J. A.W.L. C.M. R.M.B. J.S. M.N.S. B.D. R.P.M. T.R.H. L.D.M. A.P.-M. L.M.A.C. J.V.S. M.K.A. G.M. R.T.M. and J.J.S.; formal analysis, H.L.W. and R.A.; writing – original draft, H.L.W.; writing – review & editing, H.L.W. and J.B.S.; visualization, H.L.W. and K.B.-S.; supervision, H.L.W. G.M. R.T.M. B.J.B. J.J.S. and J.B.S.; project administration, H.L.W. J.J.S. and J.B.S.; funding acquisition, J.B.S. J.B.S. has a significant financial interest in and serves on the scientific advisory board of CytoDyn, a company that may have a financial interest in the results of this research and technology. This potential individual conflict of interest has been reviewed and managed by OHSU. We support inclusive, diverse, and equitable conduct of research.

FundersFunder number
CytoDyn Inc.
Fair Isaac Corporation
Foundation for AIDS Immune Research
Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of HealthAI112433, AI129703, P51 OD011092
amfAR, The Foundation for AIDS Research108832
Amgen
Oregon State University/Oregon Health and Science University
Oregon National Primate Research Center

    Keywords

    • CCR5
    • GVHD
    • HIV
    • HSCT
    • SIV

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Immunology
    • Infectious Diseases

    Fingerprint

    Dive into the research topics of 'Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques'. Together they form a unique fingerprint.

    Cite this